EAST HILLS, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE: PLL) launches the new AcrodoseTM PLus System to ensure patients receive the safest possible platelet transfusion -- no matter what type of system blood centers use to collect donated blood. In addition to increasing safety and availability of blood, Pall’s new technologies enable more efficient use of blood components by putting an end to wasting valuable and limited donations without increasing hospital or blood center costs. Along with the Acrodose PLus System, Pall is also introducing a new approach that makes universal blood collection possible. The new technologies are being showcased at the AABB annual meeting for transfusion medicine in Anaheim, California this week.
